Institute of Pathology, Faculty of Medicine, University of Ljubljana, Slovenia.
British Columbia Cancer Agency, Vancouver, Canada.
Radiol Oncol. 2014 Jul 10;48(3):282-8. doi: 10.2478/raon-2014-0010. eCollection 2014 Sep.
Microinvasive squamous cell carcinoma (MISCC) comprises a significant portion of all cervical cancers in Slovenia. Criteria of carcinomatous invasion are well described in the literature, however histopathological assessment of MISCC is difficult, because morphological characteristics can overlap with cervical intraepithelial neoplasia grade 3 (CIN 3) and other pathological changes. The aim of our study was to evaluate the reliability of the histopathological diagnosis of MISCC in Slovenia during the period from 2001 to 2007.
Data on patients with a histopathological diagnosis of cervical MISCC (FIGO stage IA) in the period of 2001 to 2007 were obtained from the Cancer Registry of Slovenia. Histological slides were obtained from the majority of pathology laboratories in Slovenia. We received 250 cases (69% of all MISCC) for the review; 30 control cases with CIN 3 and invasive squamous cell carcinoma FIGO stage IB were intermixed. The slides were coded and reviewed.
Among 250 cases originally diagnosed as MISCC, there was an agreement with MISCC diagnosis in 184 (73.6%) cases (of these 179/184 (97.3%) cases were FIGO stage IA1 and 5/184 (2.7%) cases were FIGO stage IA2). Among 179 FIGO stage IA1 cases 117 (65.4%) showed only early stromal invasion.
The retrospective review of cases diagnosed as MISCC during the period 2001-2007 in Slovenia showed a considerable number of overdiagnosed cases. Amongst cases with MISCC confirmed on review, there was a significant proportion with early stromal invasion (depth of invasion less than 1 mm).
微小浸润性鳞状细胞癌(MISCC)构成了斯洛文尼亚所有宫颈癌的重要部分。癌浸润的标准在文献中有很好的描述,然而 MISCC 的组织病理学评估很困难,因为形态特征可能与宫颈上皮内瘤变 3 级(CIN3)和其他病变重叠。我们的研究目的是评估 2001 年至 2007 年期间斯洛文尼亚 MISCC 的组织病理学诊断的可靠性。
从斯洛文尼亚癌症登记处获得了 2001 年至 2007 年间患有宫颈 MISCC(FIGO 分期 IA)的患者的组织病理学诊断数据。大多数斯洛文尼亚的病理实验室都获得了组织学切片。我们收到了 250 例(所有 MISCC 的 69%)进行复查;30 例 CIN3 和浸润性鳞状细胞癌 FIGO 分期 IB 的对照病例也被混入其中。这些切片被编码和复查。
在最初诊断为 MISCC 的 250 例病例中,有 184 例(73.6%)与 MISCC 诊断相符(其中 179/184(97.3%)病例为 FIGO 分期 IA1,5/184(2.7%)病例为 FIGO 分期 IA2)。在 179 例 FIGO 分期 IA1 病例中,有 117 例(65.4%)仅表现为早期间质浸润。
对 2001-2007 年期间诊断为 MISCC 的病例进行回顾性复查显示,存在相当数量的过度诊断病例。在复查证实的 MISCC 病例中,有相当一部分(浸润深度小于 1 毫米)表现为早期间质浸润。